User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Understanding cachexia as a cancer metabolism syndrome

Primary tabs

download
  • Open access
  • PDF
  • 1.24 M
Porporato, Paolo [UCL]

(eng) Metabolic reprogramming occurs in tumors to foster cancer cell proliferation, survival and metastasis, but as well at a systemic level affecting the whole organism, eventually leading to cancer cachexia. Indeed, as cancer cells rely on external sources of nitrogen and carbon skeleton to grow, systemic metabolic deregulation promoting tissue wasting and metabolites mobilization ultimately supports tumor growth. Cachectic patients experience a wide range of symptoms affecting several organ functions such as muscle, liver, brain, immune system and heart, collectively decreasing patients’ quality of life and worsening their prognosis. Moreover, cachexia is estimated to be the direct cause of at least 20% of cancer deaths. The main aspect of cachexia syndrome is the unstoppable skeletal muscle and fat storage wasting, even with an adequate caloric intake, resulting in nutrient mobilization – both directly as lipid and amino acids and indirectly as glucose derived from the exploitation of liver gluconeogenesis – that reaches the tumor through the bloodstream. From a metabolic standpoint, cachectic host develops a wide range of dysfunctions, from increased insulin and IGF-1 resistance to induction of mitochondrial uncoupling proteins and fat tissue browning resulting in an increased energy expenditure and heat generation, even at rest. For a long time, cachexia has been merely considered an epiphenomenon of end-stage tumors. However, in specific tumor types, such as pancreatic cancers, it is now clear that patients present markers of tissue wasting at a stage in which tumor is not yet clinically detectable, and that host amino acid supply is required for tumor growth. Indeed, tumor cells actively promote tissue wasting by secreting specific factors such as parathyroid hormone-related protein and micro RNAs. Understanding the molecular and metabolic mediators of cachexia will not only advance therapeutic approaches against cancer, but also improve patients’ quality of life.

Document type Article de périodique (Journal article) – Synthèse de littérature
Access type Accès libre
Publication date 2016
Language Anglais
Journal information "Oncogenesis" -
Peer reviewed yes
Publisher Nature Publishing Group
issn 2157-9024
e-issn 2157-9024
Publication status Accepté/Sous presse
Affiliation UCL - SSS/IREC/FATH - Pôle de Pharmacologie et thérapeutique
Links
  1. Fearon Kenneth C.H., Glass David J., Guttridge Denis C., Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways, 10.1016/j.cmet.2012.06.011
  2. Melstrom LG, Histol Histopathol, 22, 805 (2007)
  3. Argilés Josep M., López-Soriano Francisco J., Toledo Míriam, Betancourt Angelica, Serpe Roberto, Busquets Sílvia, The cachexia score (CASCO): a new tool for staging cachectic cancer patients, 10.1007/s13539-011-0027-5
  4. Johns N., Stephens N.A., Fearon K.C.H., Muscle wasting in cancer, 10.1016/j.biocel.2013.05.032
  5. Houten Lorne, Reilley Andrew A., An investigation of the cause of death from cancer, 10.1002/jso.2930130205
  6. Kalantar-Zadeh Kamyar, Rhee Connie, Sim John J., Stenvinkel Peter, Anker Stefan D., Kovesdy Csaba P., Why cachexia kills: examining the causality of poor outcomes in wasting conditions, 10.1007/s13539-013-0111-0
  7. Fearon Kenneth C.H., Baracos Vickie E., Cachexia in pancreatic cancer: new treatment options and measures of success, 10.1111/j.1477-2574.2010.00178.x
  8. Vaughan Vanessa C., Martin Peter, Lewandowski Paul A., Cancer cachexia: impact, mechanisms and emerging treatments, 10.1007/s13539-012-0087-1
  9. Evans William J., Morley John E., Argilés Josep, Bales Connie, Baracos Vickie, Guttridge Denis, Jatoi Aminah, Kalantar-Zadeh Kamyar, Lochs Herbert, Mantovani Giovanni, Marks Daniel, Mitch William E., Muscaritoli Maurizio, Najand Armine, Ponikowski Piotr, Rossi Fanelli Filippo, Schambelan Morrie, Schols Annemie, Schuster Michael, Thomas David, Wolfe Robert, Anker Stefan D., Cachexia: A new definition, 10.1016/j.clnu.2008.06.013
  10. Tisdale MJ, J Nutr, 129, 243S (1999)
  11. Argilés Josep M., Busquets Sílvia, Stemmler Britta, López-Soriano Francisco J., Cancer cachexia: understanding the molecular basis, 10.1038/nrc3829
  12. Vander Heiden M. G., Cantley L. C., Thompson C. B., Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation, 10.1126/science.1160809
  13. Coussens Lisa M., Werb Zena, Inflammation and cancer, 10.1038/nature01322
  14. Argiles Josep M., Lopez-Soriano Francisco J., Busquets Silvia, Counteracting Inflammation: A Promising Therapy in Cachexia, 10.1615/critrevoncog.v17.i3.30
  15. Mantovani Giovanni, Macciò Antonio, Mura Loredana, Massa Elena, Mudu Maria Caterina, Mulas Carlo, Lusso Maria Rita, Madeddu Clelia, Dessì Annita, Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites, 10.1007/s001090000137
  16. Torti F., Dieckmann B, Beutler B, Cerami A, Ringold G., A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia, 10.1126/science.3839597
  17. Jakubowski A A, Casper E S, Gabrilove J L, Templeton M A, Sherwin S A, Oettgen H F, Phase I trial of intramuscularly administered tumor necrosis factor in patients with advanced cancer., 10.1200/jco.1989.7.3.298
  18. Han Youqi, Weinman Steven, Boldogh Istvan, Walker Randall K., Brasier Allan R., Tumor Necrosis Factor-α-inducible IκBα Proteolysis Mediated by Cytosolic m-Calpain : A MECHANISM PARALLEL TO THE UBIQUITIN-PROTEASOME PATHWAY FOR NUCLEAR FACTOR-κB ACTIVATION, 10.1074/jbc.274.2.787
  19. Monk J. Paul, Phillips Gary, Waite Ross, Kuhn John, Schaaf Larry J., Otterson Gregory A., Guttridge Denis, Rhoades Chris, Shah Manisha, Criswell Tamara, Caligiuri Michael A., Villalona-Calero Miguel A., Assessment of Tumor Necrosis Factor Alpha Blockade As an Intervention to Improve Tolerability of Dose-Intensive Chemotherapy in Cancer Patients, 10.1200/jco.2005.04.2838
  20. Jatoi Aminah, Ritter Howard L., Dueck Amylou, Nguyen Phuong L., Nikcevich Daniel A., Luyun Ronnie F., Mattar Bassam I., Loprinzi Charles L., A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9), 10.1016/j.lungcan.2009.06.020
  21. Acharyya Swarnali, Ladner Katherine J., Nelsen Lori L., Damrauer Jeffrey, Reiser Peter J., Swoap Steven, Guttridge Denis C., Cancer cachexia is regulated by selective targeting of skeletal muscle gene products, 10.1172/jci200420174
  22. Flores E A, Bistrian B R, Pomposelli J J, Dinarello C A, Blackburn G L, Istfan N W, Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1., 10.1172/jci114059
  23. Uehara A, Am J Physiol, 257, R613 (1989)
  24. Costelli Paola, Llovera Marta, Carbó Neus, García-Martínez Cèlia, López-Sorianoq Francisco J., Argilés Josep M., Interleukin-1 receptor antagonist (IL-1ra) is unable to reverse cachexia in rats bearing an ascites hepatoma (Yoshida AH-130), 10.1016/0304-3835(95)03858-t
  25. Graziano Francesco, Ruzzo Annamaria, Santini Daniele, Humar Bostjan, Tonini Giuseppe, Catalano Vincenzo, Berardi Rossana, Pizzagalli Francesca, Arduini Federica, Bearzi Italo, Scartozzi Mario, Cascinu Stefano, Testa Enrica, Ficarelli Rita, Magnani Mauro, Prognostic Role ofInterleukin-1βGene andInterleukin-1 Receptor AntagonistGene Polymorphisms in Patients With Advanced Gastric Cancer, 10.1200/jco.2005.02.345
  26. Baltgalvis K. A., Berger F. G., Pena M. M. O., Davis J. M., Muga S. J., Carson J. A., Interleukin-6 and cachexia in ApcMin/+ mice, 10.1152/ajpregu.00716.2007
  27. Bonetto Andrea, Aydogdu Tufan, Kunzevitzky Noelia, Guttridge Denis C., Khuri Sawsan, Koniaris Leonidas G., Zimmers Teresa A., STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia, 10.1371/journal.pone.0022538
  28. Kuroda Kenji, Nakashima Jun, Kanao Kent, Kikuchi Eiji, Miyajima Akira, Horiguchi Yutaka, Nakagawa Ken, Oya Mototsugu, Ohigashi Takashi, Murai Masaru, Interleukin 6 Is Associated with Cachexia in Patients with Prostate Cancer, 10.1016/j.urology.2006.09.039
  29. Zaki Mohamed H., Nemeth Jeffrey A., Trikha Mohit, CNTO 328, a monoclonal antibody to IL-6, inhibits human tumor-induced cachexia in nude mice, 10.1002/ijc.20270
  30. Henderson J T, Seniuk N A, Richardson P M, Gauldie J, Roder J C, Systemic administration of ciliary neurotrophic factor induces cachexia in rodents., 10.1172/jci117276
  31. Seto Danielle N., Kandarian Susan C., Jackman Robert W., A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia, 10.1074/jbc.m115.638411
  32. Argilés Josep M., Busquets Sílvia, López-Soriano Francisco J., Anti-inflammatory therapies in cancer cachexia, 10.1016/j.ejphar.2011.07.007
  33. Fearon Kenneth, Arends Jann, Baracos Vickie, Understanding the mechanisms and treatment options in cancer cachexia, 10.1038/nrclinonc.2012.209
  34. Lundholm K, Cancer Res, 54, 5602 (1994)
  35. Cerchietti Leandro C.A., Navigante Alfredo H., Castro Monica A., Effects of Eicosapentaenoic and Docosahexaenoic n-3 Fatty Acids From Fish Oil and Preferential Cox-2 Inhibition on Systemic Syndromes in Patients With Advanced Lung Cancer, 10.1080/01635580701365068
  36. Bonaldo P., Sandri M., Cellular and molecular mechanisms of muscle atrophy, 10.1242/dmm.010389
  37. Cohen Shenhav, Nathan James A., Goldberg Alfred L., Muscle wasting in disease: molecular mechanisms and promising therapies, 10.1038/nrd4467
  38. Penna Fabio, Bonetto Andrea, Muscaritoli Maurizio, Costamagna Domiziana, Minero Valerio Giacomo, Bonelli Gabriella, Fanelli Filippo Rossi, Baccino Francesco Maria, Costelli Paola, Muscle atrophy in experimental cancer cachexia: Is the IGF-1 signaling pathway involved?, 10.1002/ijc.25146
  39. Asp Michelle L., Tian Min, Wendel Angela A., Belury Martha A., Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice, 10.1002/ijc.24784
  40. Costelli P., IGF-1 is downregulated in experimental cancer cachexia, 10.1152/ajpregu.00104.2006
  41. Garcia José M., Friend John, Allen Suzan, Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study, 10.1007/s00520-012-1500-1
  42. Garcia Josè M., Garcia-Touza Mariana, Hijazi Rabih A., Taffet George, Epner Daniel, Mann Douglas, Smith Roy G., Cunningham Glenn R., Marcelli Marco, Active Ghrelin Levels and Active to Total Ghrelin Ratio in Cancer-Induced Cachexia, 10.1210/jc.2004-1788
  43. Rofe AM, Anticancer Res, 14, 647 (1994)
  44. Yoshida Tadashi, Delafontaine Patrice, Mechanisms of Cachexia in Chronic Disease States, 10.1097/maj.0000000000000511
  45. Nagaya N., Uematsu M., Kojima M., Date Y., Nakazato M., Okumura H., Hosoda H., Shimizu W., Yamagishi M., Oya H., Koh H., Yutani C., Kangawa K., Elevated Circulating Level of Ghrelin in Cachexia Associated With Chronic Heart Failure: Relationships Between Ghrelin and Anabolic/Catabolic Factors, 10.1161/hc4201.097836
  46. Mantovani G., Maccio A., Madeddu C., Serpe R., Massa E., Dessi M., Panzone F., Contu P., Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia, 10.1634/theoncologist.2009-0153
  47. Lokireddy Sudarsanareddy, Wijesoma Isuru Wijerupage, Bonala Sabeera, Wei Meng, Sze Siu Kwan, McFarlane Craig, Kambadur Ravi, Sharma Mridula, Myostatin is a novel tumoral factor that induces cancer cachexia, 10.1042/bj20112024
  48. Gallot Y. S., Durieux A.-C., Castells J., Desgeorges M. M., Vernus B., Plantureux L., Remond D., Jahnke V. E., Lefai E., Dardevet D., Nemoz G., Schaeffer L., Bonnieu A., Freyssenet D. G., Myostatin Gene Inactivation Prevents Skeletal Muscle Wasting in Cancer, 10.1158/0008-5472.can-14-0057
  49. Loumaye Audrey, de Barsy Marie, Nachit Maxime, Lause Pascale, Frateur Lena, van Maanen Aline, Trefois Pierre, Gruson Damien, Thissen Jean-Paul, Role of Activin A and Myostatin in Human Cancer Cachexia, 10.1210/jc.2014-4318
  50. Zhou Xiaolan, Wang Jin Lin, Lu John, Song Yanping, Kwak Keith S., Jiao Qingsheng, Rosenfeld Robert, Chen Qing, Boone Thomas, Simonet W. Scott, Lacey David L., Goldberg Alfred L., Han H.Q., Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival, 10.1016/j.cell.2010.07.011
  51. Waning David L, Mohammad Khalid S, Reiken Steven, Xie Wenjun, Andersson Daniel C, John Sutha, Chiechi Antonella, Wright Laura E, Umanskaya Alisa, Niewolna Maria, Trivedi Trupti, Charkhzarrin Sahba, Khatiwada Pooja, Wronska Anetta, Haynes Ashley, Benassi Maria Serena, Witzmann Frank A, Zhen Gehua, Wang Xiao, Cao Xu, Roodman G David, Marks Andrew R, Guise Theresa A, Excess TGF-β mediates muscle weakness associated with bone metastases in mice, 10.1038/nm.3961
  52. Sun Yuan-Shui, Ye Zai-Yuan, Qian Zhen-Yuan, Xu Xiao-Dong, Hu Jun-Feng, Expression of TRAF6 and ubiquitin mRNA in skeletal muscle of gastric cancer patients, 10.1186/1756-9966-31-81
  53. Paul Pradyut K., Gupta Sanjay K., Bhatnagar Shephali, Panguluri Siva K., Darnay Bryant G., Choi Yongwon, Kumar Ashok, Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice, 10.1083/jcb.201006098
  54. Figueroa-Clarevega Alejandra, Bilder David, Malignant Drosophila Tumors Interrupt Insulin Signaling to Induce Cachexia-like Wasting, 10.1016/j.devcel.2015.03.001
  55. Kwon Young, Song Wei, Droujinine Ilia A., Hu Yanhui, Asara John M., Perrimon Norbert, Systemic Organ Wasting Induced by Localized Expression of the Secreted Insulin/IGF Antagonist ImpL2, 10.1016/j.devcel.2015.02.012
  56. Wagner Erwin F., Petruzzelli Michele, Cancer metabolism: A waste of insulin interference, 10.1038/521430a
  57. Lundholm K, Cancer Treat Rep, 65, 79 (1981)
  58. Baar Keith, Nader Gustavo, Bodine Sue, Resistance exercise, muscle loading/unloading and the control of muscle mass, 10.1042/bse0420061
  59. Bodine S. C., Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy, 10.1126/science.1065874
  60. Baracos VE, Am J Physiol., 268, E996 (1995)
  61. Schakman O., Kalista S., Barbé C., Loumaye A., Thissen J.P., Glucocorticoid-induced skeletal muscle atrophy, 10.1016/j.biocel.2013.05.036
  62. Temparis S, Cancer Res, 54, 5568 (1994)
  63. Sandri Marco, Sandri Claudia, Gilbert Alex, Skurk Carsten, Calabria Elisa, Picard Anne, Walsh Kenneth, Schiaffino Stefano, Lecker Stewart H, Goldberg Alfred L, Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy, 10.1016/s0092-8674(04)00400-3
  64. Cai Dongsheng, Frantz J.Daniel, Tawa Nicholas E., Melendez Peter A., Oh Byung-Chul, Lidov Hart G.W., Hasselgren Per-Olof, Frontera Walter R., Lee Jongsoon, Glass David J., Shoelson Steven E., IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice, 10.1016/j.cell.2004.09.027
  65. Chacon-Cabrera Alba, Fermoselle Clara, Urtreger Alejandro J., Mateu-Jimenez Mercè, Diament Miriam J., de Kier Joffé Elisa D. Bal, Sandri Marco, Barreiro Esther, Pharmacological Strategies in Lung Cancer-Induced Cachexia: Effects on Muscle Proteolysis, Autophagy, Structure, and Weakness : MUSCLE BIOLOGY, STRUCTURE, AND FUNCTION IN CACHEXIA, 10.1002/jcp.24611
  66. Bossola Maurizio, Muscaritoli Maurizio, Costelli Paola, Grieco Gabriella, Bonelli Gabriella, Pacelli Fabio, Fanelli Filippo, Doglietto Giovanni, Baccino Francesco, 10.1097/00000658-200303000-00013
  67. Milan Giulia, Romanello Vanina, Pescatore Francesca, Armani Andrea, Paik Ji-Hye, Frasson Laura, Seydel Anke, Zhao Jinghui, Abraham Reimar, Goldberg Alfred L., Blaauw Bert, DePinho Ronald A., Sandri Marco, Regulation of autophagy and the ubiquitin–proteasome system by the FoxO transcriptional network during muscle atrophy, 10.1038/ncomms7670
  68. Penna Fabio, Costamagna Domiziana, Pin Fabrizio, Camperi Andrea, Fanzani Alessandro, Chiarpotto Elena M., Cavallini Gabriella, Bonelli Gabriella, Baccino Francesco M., Costelli Paola, Autophagic Degradation Contributes to Muscle Wasting in Cancer Cachexia, 10.1016/j.ajpath.2012.12.023
  69. McClung J. M., Judge A. R., Powers S. K., Yan Z., p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting, 10.1152/ajpcell.00192.2009
  70. Op den Kamp C. M., Langen R. C., Snepvangers F. J., de Theije C. C., Schellekens J. M., Laugs F., Dingemans A.-M. C., Schols A. M., Nuclear transcription factor   B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia, 10.3945/ajcn.113.058388
  71. Tardif N., Klaude M., Lundell L., Thorell A., Rooyackers O., Autophagic-lysosomal pathway is the main proteolytic system modified in the skeletal muscle of esophageal cancer patients, 10.3945/ajcn.113.063859
  72. Boyer-Guittaut Michaël, Poillet Laura, Liang Qiuli, Bôle-Richard Elodie, Ouyang Xiaosen, Benavides Gloria A, Chakrama Fatima-Zahra, Fraichard Annick, Darley-Usmar Victor M, Despouy Gilles, Jouvenot Michèle, Delage-Mourroux Régis, Zhang Jianhua, The role of GABARAPL1/GEC1 in autophagic flux and mitochondrial quality control in MDA-MB-436 breast cancer cells, 10.4161/auto.28390
  73. Stephens Nathan A., Skipworth Richard J. E., Gallagher Iain J., Greig Carolyn A., Guttridge Denis C., Ross James A., Fearon Kenneth C. H., Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients : Evaluating potential biomarkers of cachexia and survival, 10.1002/jcsm.12005
  74. Costelli Paola, Reffo Patrizia, Penna Fabio, Autelli Riccardo, Bonelli Gabriella, Baccino Francesco M., Ca2+-dependent proteolysis in muscle wasting, 10.1016/j.biocel.2005.03.010
  75. He Wei A., Berardi Emanuele, Cardillo Veronica M., Acharyya Swarnali, Aulino Paola, Thomas-Ahner Jennifer, Wang Jingxin, Bloomston Mark, Muscarella Peter, Nau Peter, Shah Nilay, Butchbach Matthew E.R., Ladner Katherine, Adamo Sergio, Rudnicki Michael A., Keller Charles, Coletti Dario, Montanaro Federica, Guttridge Denis C., NF-κB–mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia, 10.1172/jci68523
  76. He W. A., Calore F., Londhe P., Canella A., Guttridge D. C., Croce C. M., Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7, 10.1073/pnas.1402714111
  77. Tzika AA, Int J Oncol, 43, 886 (2013)
  78. Antunes Diana, Padrão Ana Isabel, Maciel Elisabete, Santinha Deolinda, Oliveira Paula, Vitorino Rui, Moreira-Gonçalves Daniel, Colaço Bruno, Pires Maria João, Nunes Cláudia, Santos Lúcio L., Amado Francisco, Duarte José Alberto, Domingues Maria Rosário, Ferreira Rita, Molecular insights into mitochondrial dysfunction in cancer-related muscle wasting, 10.1016/j.bbalip.2014.03.004
  79. McLean Julie B., Moylan Jennifer S., Andrade Francisco H., Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes, 10.3389/fphys.2014.00503
  80. Bing C, Russell S T, Beckett E E, Collins P, Taylor S, Barraclough R, Tisdale M J, Williams G, Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor, 10.1038/sj.bjc.6600101
  81. Sanchı́s Daniel, Busquets Sı́lvia, Alvarez Belén, Ricquier Daniel, López-Soriano Francisco J, Argilés Josep M, Skeletal muscle UCP2 and UCP3 gene expression in a rat cancer cachexia model, 10.1016/s0014-5793(98)01178-8
  82. Collins P, Bing C, McCulloch P, Williams G, Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans, 10.1038/sj.bjc.6600074
  83. Divakaruni A. S., Brand M. D., The Regulation and Physiology of Mitochondrial Proton Leak, 10.1152/physiol.00046.2010
  84. Nedergaard Jan, Ricquier Daniel, Kozak Leslie P., Uncoupling proteins: current status and therapeutic prospects, 10.1038/sj.embor.7400532
  85. Ushmorov A, Cancer Res, 59, 3527 (1999)
  86. Barreiro Esther, Protein carbonylation and muscle function in COPD and other conditions : SKELETAL MUSCLE PROTEIN CARBONYLATION IN DISEASE, 10.1002/mas.21394
  87. Argilés Josep M., Fontes-Oliveira Cibely Cristine, Toledo Miriam, López-Soriano Francisco J., Busquets Sílvia, Cachexia: a problem of energetic inefficiency, 10.1007/s13539-014-0154-x
  88. Zentella Alejandro, Manogue Kirk, Cerami Anthony, Cachectin/TNF-mediated lactate production in cultured myocytes is linked to activation of a futile substrate cycle, 10.1016/1043-4666(93)90033-2
  89. Willis Monte S., Bevilacqua Ariana, Pulinilkunnil Thomas, Kienesberger Petra, Tannu Manasi, Patterson Cam, The role of ubiquitin ligases in cardiac disease, 10.1016/j.yjmcc.2013.11.008
  90. Tian M, Int J Oncol, 37, 347 (2010)
  91. Wysong Ashley, Couch Marion, Shadfar Scott, Li Lugi, Rodriguez Jessica E., Asher Scott, Yin Xiaoying, Gore Mitchell, Baldwin Al, Patterson Cam, Willis Monte S., NF-κB Inhibition Protects against Tumor-Induced Cardiac Atrophy in Vivo, 10.1016/j.ajpath.2010.12.009
  92. Mustafa Iqbal, Leverve Xavier, Metabolic and nutritional disorders in cardiac cachexia, 10.1016/s0899-9007(01)00627-x
  93. Drott Christer, Lundholm Kent, Glucose uptake and amino acid metabolism in perfused hearts from tumor-bearing rats, 10.1016/0022-4804(90)90112-f
  94. Lieffers J. R, Mourtzakis M., Hall K. D, McCargar L. J, Prado C. M., Baracos V. E, A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands, 10.3945/ajcn.2008.27273
  95. Tisdale Michael J., Cachexia in cancer patients, 10.1038/nrc927
  96. Julienne Cloé Mimsy, Tardieu Marine, Chevalier Stéphan, Pinault Michelle, Bougnoux Philippe, Labarthe François, Couet Charles, Servais Stéphane, Dumas Jean-François, Cardiolipin content is involved in liver mitochondrial energy wasting associated with cancer-induced cachexia without the involvement of adenine nucleotide translocase, 10.1016/j.bbadis.2014.02.003
  97. Dumas Jean-François, Goupille Caroline, Julienne Cloé Mimsy, Pinault Michelle, Chevalier Stéphan, Bougnoux Philippe, Servais Stéphane, Couet Charles, Efficiency of oxidative phosphorylation in liver mitochondria is decreased in a rat model of peritoneal carcinosis, 10.1016/j.jhep.2010.08.012
  98. Holroyde CP, Cancer Res, 44, 5910 (1984)
  99. Tisdale M. J., Mechanisms of Cancer Cachexia, 10.1152/physrev.00016.2008
  100. George A, J Biol Chem, 238, 495 (1963)
  101. Holroyde CP, Cancer Res, 35, 3710 (1975)
  102. Fenninger Leonard D., Mider G.Burroughs, Energy and Nitrogen Metabolism in Cancer, Advances in Cancer Research (1954) ISBN:9780120066025 p.229-253, 10.1016/s0065-230x(08)60496-0
  103. Diaz Mauricio Berriel, Krones-Herzig Anja, Metzger Dagmar, Ziegler Anja, Vegiopoulos Alexandros, Klingenspor Martin, Müller-Decker Karin, Herzig Stephan, Nuclear receptor cofactor receptor interacting protein 140 controls hepatic triglyceride metabolism during wasting in mice, 10.1002/hep.22383
  104. Martignoni ME, Oncol Rep, 21, 363 (2009)
  105. Jones Allan, Friedrich Kilian, Rohm Maria, Schäfer Michaela, Algire Carolyn, Kulozik Philipp, Seibert Oksana, Müller-Decker Karin, Sijmonsma Tjeerd, Strzoda Daniela, Sticht Carsten, Gretz Norbert, Dallinga-Thie Geesje M., Leuchs Barbara, Kögl Manfred, Stremmel Wolfgang, Diaz Mauricio Berriel, Herzig Stephan, TSC22D4 is a molecular output of hepatic wasting metabolism : TSC22D4 regulates hepatic lipid handling, 10.1002/emmm.201201869
  106. Sunny Nishanth E., Parks Elizabeth J., Browning Jeffrey D., Burgess Shawn C., Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver Disease, 10.1016/j.cmet.2011.11.004
  107. Patra Surajeet K., Arora Sarika, Integrative role of neuropeptides and cytokines in cancer anorexia–cachexia syndrome, 10.1016/j.cca.2011.12.008
  108. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL, Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients, 10.1053/ajkd.1998.v32.pm9669431
  109. Brenner D A, Buck M, Feitelberg S P, Chojkier M, Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia., 10.1172/jci114419
  110. Hennig B, J Nutr, 118, 1586 (1988)
  111. Fearon Kenneth C. H., Falconer J. Stuart, Slater Christine, McMillan Donald C., Ross James A., Preston Tom, Albumin Synthesis Rates Are Not Decreased in Hypoalbuminemic Cachectic Cancer Patients With an Ongoing Acute-Phase Protein Response : , 10.1097/00000658-199802000-00015
  112. Commisso Cosimo, Davidson Shawn M., Soydaner-Azeloglu Rengin G., Parker Seth J., Kamphorst Jurre J., Hackett Sean, Grabocka Elda, Nofal Michel, Drebin Jeffrey A., Thompson Craig B., Rabinowitz Joshua D., Metallo Christian M., Vander Heiden Matthew G., Bar-Sagi Dafna, Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells, 10.1038/nature12138
  113. Kamphorst J. J., Nofal M., Commisso C., Hackett S. R., Lu W., Grabocka E., Vander Heiden M. G., Miller G., Drebin J. A., Bar-Sagi D., Thompson C. B., Rabinowitz J. D., Human Pancreatic Cancer Tumors Are Nutrient Poor and Tumor Cells Actively Scavenge Extracellular Protein, 10.1158/0008-5472.can-14-2211
  114. Costa G, Cancer Res, 22, 1081 (1962)
  115. Das S. K., Eder S., Schauer S., Diwoky C., Temmel H., Guertl B., Gorkiewicz G., Tamilarasan K. P., Kumari P., Trauner M., Zimmermann R., Vesely P., Haemmerle G., Zechner R., Hoefler G., Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia, 10.1126/science.1198973
  116. SHAW JAMES H. F., WOLFE ROBERT R., Fatty Acid and Glycerol Kinetics in Septic Patients and in Patients with Gastrointestinal Cancer : The Response to Glucose Infusion and Parenteral Feeding, 10.1097/00000658-198704000-00005
  117. Das Suman K., Hoefler Gerald, The role of triglyceride lipases in cancer associated cachexia, 10.1016/j.molmed.2013.02.006
  118. Russell Steven T., Tisdale Michael J., Mechanism of Attenuation of Skeletal Muscle Atrophy by Zinc-α2-Glycoprotein, 10.1210/en.2010-0532
  119. Kir Serkan, White James P., Kleiner Sandra, Kazak Lawrence, Cohen Paul, Baracos Vickie E., Spiegelman Bruce M., Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia, 10.1038/nature13528
  120. Petruzzelli Michele, Schweiger Martina, Schreiber Renate, Campos-Olivas Ramon, Tsoli Maria, Allen John, Swarbrick Michael, Rose-John Stefan, Rincon Mercedes, Robertson Graham, Zechner Rudolf, Wagner Erwin F., A Switch from White to Brown Fat Increases Energy Expenditure in Cancer-Associated Cachexia, 10.1016/j.cmet.2014.06.011
  121. Puigserver Pere, Wu Zhidan, Park Cheol Won, Graves Reed, Wright Margaret, Spiegelman Bruce M, A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis, 10.1016/s0092-8674(00)81410-5
  122. Stewart Andrew F., Hypercalcemia Associated with Cancer, 10.1056/nejmcp042806
  123. Carracedo Arkaitz, Cantley Lewis C., Pandolfi Pier Paolo, Cancer metabolism: fatty acid oxidation in the limelight, 10.1038/nrc3483
  124. DeWys WD, J Hum Nutr, 32, 447 (1978)
  125. Martínez-Sánchez Noelia, Alvarez Clara V., Fernø Johan, Nogueiras Rubén, Diéguez Carlos, López Miguel, Hypothalamic effects of thyroid hormones on metabolism, 10.1016/j.beem.2014.04.004
  126. Anand B. K., Pillai R. V., Activity of single neurones in the hypothalamic feeding centres: effect of gastric distension, 10.1113/jphysiol.1967.sp008288
  127. Wang Gene-Jack, Tomasi Dardo, Backus Walter, Wang Ruiliang, Telang Frank, Geliebter Allan, Korner Judith, Bauman Angela, Fowler Joanna S., Thanos Panayotis K., Volkow Nora D., Gastric distention activates satiety circuitry in the human brain, 10.1016/j.neuroimage.2007.11.008
  128. Moran Timothy H., Dailey Megan J., Intestinal feedback signaling and satiety, 10.1016/j.physbeh.2011.02.005
  129. Laviano Alessandro, Russo Mariarita, Freda Francesca, Rossi-Fanelli Filippo, Neurochemical mechanisms for cancer anorexia, 10.1016/s0899-9007(01)00727-4
  130. Stoffel-Wagner B, Neurosteroid metabolism in the human brain, 10.1530/eje.0.1450669
  131. Chance W.T., Balasubramaniam A., Borchers M., Fischer J.E., Refractory hypothalamic adenylate cyclase in anorectic tumor-bearing rats: implications for NPY-induced feeding, 10.1016/0006-8993(95)00716-4
  132. Chance William T., Xiao Chun, Dayal Ramesh, Sheriff Sulaiman, Alteration of NPY and Y1 receptor in dorsomedial and ventromedial areas of hypothalamus in anorectic tumor-bearing rats, 10.1016/j.peptides.2006.10.018
  133. Laviano A., Inui A., Marks D. L., Meguid M. M., Pichard C., Rossi Fanelli F., Seelaender M., Neural control of the anorexia-cachexia syndrome, 10.1152/ajpendo.90252.2008
  134. Silva Vagner R. R., Micheletti Thayana O., Pimentel Gustavo D., Katashima Carlos K., Lenhare Luciene, Morari Joseane, Mendes Maria Carolina S., Razolli Daniela S., Rocha Guilherme Z., de Souza Claudio T., Ryu Dongryeol, Prada Patrícia O., Velloso Lício A., Carvalheira José B. C., Rodrigo Pauli José, Cintra Dennys E., Ropelle Eduardo R., Hypothalamic S1P/S1PR1 axis controls energy homeostasis, 10.1038/ncomms5859
  135. Laviano Alessandro, Meguid Michael M, Inui Akio, Muscaritoli Maurizio, Rossi-Fanelli Filippo, Therapy Insight: cancer anorexia–cachexia syndrome—when all you can eat is yourself, 10.1038/ncponc0112
  136. Cahlin C, Cancer Res, 60, 1742 (2000)
  137. Davis T. W., Inhibition of Cyclooxygenase-2 by Celecoxib Reverses Tumor-Induced Wasting, 10.1124/jpet.103.063099
  138. Feng Pu, Jyotaki Masafumi, Kim Agnes, Chai Jinghua, Simon Nirvine, Zhou Minliang, Bachmanov Alexander A., Huang Liquan, Wang Hong, Regulation of bitter taste responses by tumor necrosis factor, 10.1016/j.bbi.2015.04.001
  139. Kluger M., Rothenburg B., Fever and reduced iron: their interaction as a host defense response to bacterial infection, 10.1126/science.760197
  140. Cahlin C, Cancer Res, 60, 5488 (2000)
  141. Bing Chen, Taylor Sue, Tisdale Michael J., Williams Gareth, Cachexia in MAC16 adenocarcinoma: suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y : Regulation of leptin and NPY in cachexia, 10.1046/j.1471-4159.2001.00639.x
  142. Maceyka Michael, Harikumar Kuzhuvelil B., Milstien Sheldon, Spiegel Sarah, Sphingosine-1-phosphate signaling and its role in disease, 10.1016/j.tcb.2011.09.003
  143. Williams Kevin W, Elmquist Joel K, From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior, 10.1038/nn.3217
  144. Grossberg Aaron J., Scarlett Jarrad M., Marks Daniel L., Hypothalamic mechanisms in cachexia, 10.1016/j.physbeh.2010.03.011
  145. Tchekmedyian NS, Semin Oncol, 13, 37 (1986)
  146. Tayek J A, A review of cancer cachexia and abnormal glucose metabolism in humans with cancer., 10.1080/07315724.1992.10718249
  147. Bruning Peter F., Bonfrèr Johannes M. G., van Noord Paul A. H., Hart Augustinus A. M., de Jong-Bakker Maartje, Nooijen Wim J., Insulin resistance and breast-cancer risk, 10.1002/ijc.2910520402
  148. Renehan Andrew G., Frystyk Jan, Flyvbjerg Allan, Obesity and cancer risk: the role of the insulin–IGF axis, 10.1016/j.tem.2006.08.006
  149. Glicksman Arvin S., Rawson Rulon W., Diabetes and altered carbohydrate metabolism in patients with cancer, 10.1002/1097-0142(195611/12)9:6<1127::aid-cncr2820090610>3.0.co;2-4
  150. Honors Mary A., Kinzig Kimberly P., The role of insulin resistance in the development of muscle wasting during cancer cachexia, 10.1007/s13539-011-0051-5
  151. Parekh Niyati, Lin Yong, Hayes Richard B., Albu Jeanine B., Lu-Yao Grace L., Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey, 10.1007/s10552-009-9492-y
  152. Fernandes LC, Am J Physiol, 258, E1033 (1990)
  153. Hotamisligil G. S., Murray D. L., Choy L. N., Spiegelman B. M., Tumor necrosis factor alpha inhibits signaling from the insulin receptor., 10.1073/pnas.91.11.4854
  154. Brooks P C, Klemke R L, Schon S, Lewis J M, Schwartz M A, Cheresh D A, Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo., 10.1172/jci119298
  155. Massoner P, Ladurner-Rennau M, Eder I E, Klocker H, Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer, 10.1038/sj.bjc.6605932
  156. Cullen KJ, Cancer Res, 50, 48 (1990)
  157. Maloney EK, Cancer Res, 63, 5073 (2003)
  158. Gelfand R A, Barrett E J, Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man., 10.1172/jci113033
  159. Lecker Stewart H., Solomon Vered, Price S. Russ, Kwon Yong Tae, Mitch William E., Goldberg Alfred L., Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats, 10.1172/jci7300
  160. Hanson Richard W., Reshef Lea, REGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION, 10.1146/annurev.biochem.66.1.581
  161. Asp Michelle L., Tian Min, Kliewer Kara L., Belury Martha A., Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia, 10.4161/cbt.12.11.18134
  162. Lundholm K., Korner U., Gunnebo L., Sixt-Ammilon P., Fouladiun M., Daneryd P., Bosaeus I., Insulin Treatment in Cancer Cachexia: Effects on Survival, Metabolism, and Physical Functioning, 10.1158/1078-0432.ccr-06-2720
  163. BARTLETT D, CHARLAND S, TOROSIAN M, Reversal of tumor-associated hyperglucagonemia as treatment for cancer cachexia*, 10.1016/s0039-6060(05)80014-5
  164. Hartl Wolfgang H., Demmelmair Hans, Jauch Karl-Walter, Koletzko Berthold, Schildberg Friedrich W., Effect of Glucagon on Protein Synthesis in Human Rectal Cancer In Situ : , 10.1097/00000658-199803000-00011
  165. Inculet RI, J Natl Cancer Inst, 79, 1039 (1987)
  166. Puppa Melissa J., White James P., Sato Shuichi, Cairns Mark, Baynes John W., Carson James A., Gut barrier dysfunction in the ApcMin/+ mouse model of colon cancer cachexia, 10.1016/j.bbadis.2011.08.010
  167. Klein Gerald L., Petschow Bryon W., Shaw Audrey L., Weaver Eric, Gut barrier dysfunction and microbial translocation in cancer cachexia : a new therapeutic target, 10.1097/spc.0000000000000017
  168. Bindels Laure B., Delzenne Nathalie M., Muscle wasting: The gut microbiota as a new therapeutic target?, 10.1016/j.biocel.2013.06.021
  169. Cani P. D., Gut microbiota and obesity: lessons from the microbiome, 10.1093/bfgp/elt014
  170. Bindels Laure B., Neyrinck Audrey M., Salazar Nuria, Taminiau Bernard, Druart Céline, Muccioli Giulio G., François Emmanuelle, Blecker Christophe, Richel Aurore, Daube Georges, Mahillon Jacques, de los Reyes-Gavilán Clara G., Cani Patrice D., Delzenne Nathalie M., Non Digestible Oligosaccharides Modulate the Gut Microbiota to Control the Development of Leukemia and Associated Cachexia in Mice, 10.1371/journal.pone.0131009
  171. Bindels L B, Porporato P, Dewulf E M, Verrax J, Neyrinck A M, Martin J C, Scott K P, Buc Calderon P, Feron O, Muccioli G G, Sonveaux P, Cani P D, Delzenne N M, Gut microbiota-derived propionate reduces cancer cell proliferation in the liver, 10.1038/bjc.2012.409
  172. Bindels Laure B., Beck Raphaël, Schakman Olivier, Martin Jennifer C., De Backer Fabienne, Sohet Florence M., Dewulf Evelyne M., Pachikian Barbara D., Neyrinck Audrey M., Thissen Jean-Paul, Verrax Julien, Calderon Pedro Buc, Pot Bruno, Grangette Corinne, Cani Patrice D., Scott Karen P., Delzenne Nathalie M., Restoring Specific Lactobacilli Levels Decreases Inflammation and Muscle Atrophy Markers in an Acute Leukemia Mouse Model, 10.1371/journal.pone.0037971
  173. Heppner K. M., Piechowski C. L., Muller A., Ottaway N., Sisley S., Smiley D. L., Habegger K. M., Pfluger P. T., DiMarchi R., Biebermann H., Tschop M. H., Sandoval D. A., Perez-Tilve D., Both Acyl and Des-Acyl Ghrelin Regulate Adiposity and Glucose Metabolism via Central Nervous System Ghrelin Receptors, 10.2337/db13-0414
  174. St-Pierre David H., Karelis Antony D., Cianflone Katherine, Conus Florence, Mignault Diane, Rabasa-Lhoret Remi, St-Onge Maxime, Tremblay-Lebeau Andréanne, Poehlman Eric T., Relationship between Ghrelin and Energy Expenditure in Healthy Young Women, 10.1210/jc.2004-0613
  175. Porporato PE, J Clin Invest, 123, 611 (2013)
  176. Ruozi Giulia, Bortolotti Francesca, Falcione Antonella, Dal Ferro Matteo, Ukovich Laura, Macedo Antero, Zentilin Lorena, Filigheddu Nicoletta, Cappellari Gianluca Gortan, Baldini Giovanna, Zweyer Marina, Barazzoni Rocco, Graziani Andrea, Zacchigna Serena, Giacca Mauro, AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia, 10.1038/ncomms8388
  177. Filigheddu N., Gnocchi V. F., Coscia M., Cappelli M., Porporato P. E., Taulli R., Traini S., Baldanzi G., Chianale F., Cutrupi S., Arnoletti E., Ghe C., Fubini A., Surico N., Sinigaglia F., Ponzetto C., Muccioli G., Crepaldi T., Graziani A., Ghrelin and Des-Acyl Ghrelin Promote Differentiation and Fusion of C2C12 Skeletal Muscle Cells, 10.1091/mbc.e06-05-0402
  178. Garcia José M, Boccia Ralph V, Graham Charles D, Yan Ying, Duus Elizabeth Manning, Allen Suzan, Friend John, Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials, 10.1016/s1470-2045(14)71154-4
  179. Al-Zhoughbi Wael, Huang Jianfeng, Paramasivan Ganapathy S., Till Holger, Pichler Martin, Guertl-Lackner Barbara, Hoefler Gerald, Tumor Macroenvironment and Metabolism, 10.1053/j.seminoncol.2014.02.005
  180. Mayers Jared R, Wu Chen, Clish Clary B, Kraft Peter, Torrence Margaret E, Fiske Brian P, Yuan Chen, Bao Ying, Townsend Mary K, Tworoger Shelley S, Davidson Shawn M, Papagiannakopoulos Thales, Yang Annan, Dayton Talya L, Ogino Shuji, Stampfer Meir J, Giovannucci Edward L, Qian Zhi Rong, Rubinson Douglas A, Ma Jing, Sesso Howard D, Gaziano John M, Cochrane Barbara B, Liu Simin, Wactawski-Wende Jean, Manson JoAnn E, Pollak Michael N, Kimmelman Alec C, Souza Amanda, Pierce Kerry, Wang Thomas J, Gerszten Robert E, Fuchs Charles S, Vander Heiden Matthew G, Wolpin Brian M, Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development, 10.1038/nm.3686
  181. Hanahan Douglas, Weinberg Robert A., Hallmarks of Cancer: The Next Generation, 10.1016/j.cell.2011.02.013
  182. Carmeliet Peter, Jain Rakesh K., Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases, 10.1038/nrd3455
  183. Porporato Paolo E., Dhup Suveera, Dadhich Rajesh K., Copetti Tamara, Sonveaux Pierre, Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review, 10.3389/fphar.2011.00049
  184. De Saedeleer C J, Porporato P E, Copetti T, Pérez-Escuredo J, Payen V L, Brisson L, Feron O, Sonveaux P, Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration, 10.1038/onc.2013.454
  185. Lewis C A, Brault C, Peck B, Bensaad K, Griffiths B, Mitter R, Chakravarty P, East P, Dankworth B, Alibhai D, Harris A L, Schulze A, SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme, 10.1038/onc.2014.439
  186. Nieman Kristin M, Kenny Hilary A, Penicka Carla V, Ladanyi Andras, Buell-Gutbrod Rebecca, Zillhardt Marion R, Romero Iris L, Carey Mark S, Mills Gordon B, Hotamisligil Gökhan S, Yamada S Diane, Peter Marcus E, Gwin Katja, Lengyel Ernst, Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth, 10.1038/nm.2492
  187. Tönjes Martje, Barbus Sebastian, Park Yoon Jung, Wang Wei, Schlotter Magdalena, Lindroth Anders M, Pleier Sabrina V, Bai Alfa H C, Karra Daniela, Piro Rosario M, Felsberg Jörg, Addington Adele, Lemke Dieter, Weibrecht Irene, Hovestadt Volker, Rolli Claudio G, Campos Benito, Turcan Sevin, Sturm Dominik, Witt Hendrik, Chan Timothy A, Herold-Mende Christel, Kemkemer Ralf, König Rainer, Schmidt Kathrin, Hull William-Edmund, Pfister Stefan M, Jugold Manfred, Hutson Susan M, Plass Christoph, Okun Jürgen G, Reifenberger Guido, Lichter Peter, Radlwimmer Bernhard, BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1, 10.1038/nm.3217
  188. Son Jaekyoung, Lyssiotis Costas A., Ying Haoqiang, Wang Xiaoxu, Hua Sujun, Ligorio Matteo, Perera Rushika M., Ferrone Cristina R., Mullarky Edouard, Shyh-Chang Ng, Kang Ya’an, Fleming Jason B., Bardeesy Nabeel, Asara John M., Haigis Marcia C., DePinho Ronald A., Cantley Lewis C., Kimmelman Alec C., Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway, 10.1038/nature12040
  189. Dang Chi V., MYC on the Path to Cancer, 10.1016/j.cell.2012.03.003
  190. Maddocks Oliver D. K., Berkers Celia R., Mason Susan M., Zheng Liang, Blyth Karen, Gottlieb Eyal, Vousden Karen H., Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells, 10.1038/nature11743
  191. Luo Y., Yoneda J., Ohmori H., Sasaki T., Shimbo K., Eto S., Kato Y., Miyano H., Kobayashi T., Sasahira T., Chihara Y., Kuniyasu H., Cancer Usurps Skeletal Muscle as an Energy Repository, 10.1158/0008-5472.can-13-1052
  192. Schmidt Ann Marie, Taguchi Akihiko, Blood David C., del Toro Gustavo, Canet Anthony, Lee Daniel C., Qu Wu, Tanji Nozomu, Lu Yan, Lalla Evanthia, Fu Caifeng, Hofmann Marion A., Kislinger Thomas, Ingram Mark, Lu Amy, Tanaka Hidekazu, Hori Osamu, Ogawa Satoshi, Stern David M., 10.1038/35012626
  193. Yan He-Xin, Wu Hong-Ping, Zhang Hui-Lu, Ashton Charles, Tong Chang, Wu Han, Qian Qi-Jun, Wang Hong-Yang, Ying Qi-Long, p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release, 10.1016/j.jhep.2013.05.029
  194. Tabata Chiharu, Shibata Eisuke, Tabata Rie, Kanemura Shingo, Mikami Koji, Nogi Yoshitaka, Masachika Eriko, Nishizaki Tomoyuki, Nakano Takashi, Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma, 10.1186/1471-2407-13-205
  195. Fearon Kenneth, Strasser Florian, Anker Stefan D, Bosaeus Ingvar, Bruera Eduardo, Fainsinger Robin L, Jatoi Aminah, Loprinzi Charles, MacDonald Neil, Mantovani Giovanni, Davis Mellar, Muscaritoli Maurizio, Ottery Faith, Radbruch Lukas, Ravasco Paula, Walsh Declan, Wilcock Andrew, Kaasa Stein, Baracos Vickie E, Definition and classification of cancer cachexia: an international consensus, 10.1016/s1470-2045(10)70218-7
Bibliographic reference Porporato, Paolo. Understanding cachexia as a cancer metabolism syndrome. In: Oncogenesis,
Permanent URL http://hdl.handle.net/2078.1/170422